FindTrial
Sign In

Prognostic value of the extent of lymphadenectomy for overall survival among non-muscle invasive bladder cancer patients, a retrospective cohort study

Prognostic value of the extent of lymphadenectomy for overall survival among non-muscle invasive bladder cancer patients, a retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094409
Enrollment
Unknown
Registered
2024-12-23
Start date
2024-12-25
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

group with adequate lymph node dissection:NA
group with restricted lymph node dissection:NA

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 199 Years

Inclusion criteria

Inclusion criteria: 1.diagnosed with non-muscle-invasive bladder cancer 2.underwent cystectomy

Exclusion criteria

Exclusion criteria: 1.receive neoadjuvant therapy 2.unknown number of lymph node dissection 3.survival less than 3 months 4.distant metastasis 5.unknown clinical information

Design outcomes

Primary

MeasureTime frame
overall survival;number of lymph node examined;—

Secondary

MeasureTime frame
age;race;marital status;gender;number of positive lymph node ;chemotherapy;histology;tumor grade;cancer specific survival;—

Countries

China

Contacts

Public ContactHao Hu

Peking University People's Hospital

huhao@bjmu.edu.cn+86 176 2910 4894

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026